References
- Prata N, Gerdts C. Measurement of postpartum blood loss. BMJ 2010;340:c555
- Stafford I, Dildy GA, Clark SL, Belfort MA. Visually estimated and calculated blood loss in vaginal and cesarean delivery. Am J Obstet Gynecol 2008;199:519 . e1–7
- Naef RW III, Chauhan SP, Chevalier SP, et al. Prediction of hemorrhage at cesarean delivery. Obstet Gynecol 1994;83:923–6
- Jansen AJ, van Rhenen DJ, Steegers EA, et al. Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005;60:663–71
- Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69–76
- Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour (Cochrane review). The Cochrane library. Oxford, UK: Update Software; 2003
- McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev 2004;(1):CD000201
- Elbourne DR, Prendiville WJ, Carroli G. Prophylactic use of oxytocin in the third stage of labour (Cochrane Review). The Cochrane Library. Oxford, UK: Update Software; 2003
- Bouwmeester FW, Boltc AC, van Geijn HP. Pharmacological and surgical therapy for primary postpartum haemorrhage. Curr Pharm Des 2005;11:759–73
- Chong Y-S, Su L-L, Arulkumaran S. Current strategies for the prevention of postpartum haemorrhage in the third stage of labour. Curr Opin Obstet Gynecol 2004;16:143–50
- Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section–a survey of practice in the United Kingdom. Eur J Obstet Gynecol Reprod Biol 2008;137:27–30
- Chard T, Boyd N, Forsling M. The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from plasma, and its measurement during parturition in human and goat blood. J Endocrinol 1970;48:223–34
- Liabsuetrakul T, Choobun T, Peeyanajarassri K, Islam QM. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev 2007;18:CD005456
- Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 1992;52:60–7
- Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG 2010;117:929–36
- Prendiville W, Harding JE, Elbourne DR, Stirrat GM. The Bristol third stage trial: active versus physiological management of the third stage of labor. BMJ 1988;297:1295–300
- Rogers J, Wood J, McCandlish R, et al. Active versus expectant management of third stage of labor: the Hinchingbrooke randomized controlled trial. Lancet 1998;351:693–9
- Reyes OA, Gonzalez GM. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in patients with severe preeclampsia: a double-blind randomized controlled trial. J Obstet Gynaecol Can 2011;33:1099–104
- Boucher M, Nimrod CA, Tawagi GF, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a double-blind randomized trial. J Obstet Gynaecol Can 2004;26:481–8
- Leung SW, Ng PS, Wong WY, Cheung TH. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG 2006;113:1459–64
- Samimi M, Harsini AI, Kalahroudi M. Carbetocin vs. syntometrine in prevention of postpartum hemorrhage: a double blind randomized control trial. Iran Red Crescent Med J 2013;15:817–22
- Moertl MG, Friedrich S, Kraschl J, et al. Haemodynamic effects of carbitocin and oxytocin given as IV bolus on women undergoing CS. BJOG 2011;118:1349–56